Top-News

Vivus News

Keine aktuellen Kursdaten verfügbar
WKN: A2N5RJ
ISIN: US9285513084
US-Symbol: VVUS
Typ: Aktie

Vivus News

03.04.20 - PR Newswire
VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules
VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules PR Newswire
20.08.19 - PR Newswire
Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus?
Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus? PR Newswire
14.03.19 - ACCESSWIRE
VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction
CAMPBELL, CA / ACCESSWIRE / March 14, 2019 / VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced that the Ministry of Health of the ...
17.05.16 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of VIVUS Inc. - VVUS
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of VIVUS Inc. - VVUS PR Newswire
16.05.16 - PR Newswire
Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating VIVUS, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating VIVUS, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
29.12.15 - PR Newswire
A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss New ...
29.12.15 - PR Newswire
A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss New ...
30.10.15 - sharedeals.de
Vivus: Mutimilliardär Icahn steigt als Hauptgläubiger ein
Es ist offiziell: Star-​Investor Carl Icahn wird bei Vivus (WKN: 893380) die Mehrheit der ausstehenden Convertible Notes übernehmen und damit zum Hauptgläubiger des ...
08.10.15 - sharedeals.de
Vivus: Mutimilliardär Icahn steigt als Hauptgläubiger ein
Es ist offiziell: Star-​Investor Carl Icahn wird bei Vivus (WKN: 893380) die Mehrheit der ausstehenden Convertible Notes übernehmen und damit zum Hauptgläubiger des ...
01.10.15 - sharedeals.de
Vivus: Icahn bekräftigt Übernahme­angebot für Convertible Notes
Multimilliardär und Star-​Investor Carl Icahn hat sein erstmals Anfang September eingereichtes Angebot zur Übernahme aller ausstehenden Convertible Notes des US-...
19.09.15 - sharedeals.de
Biopharma-Geldsegen: Can-Fite, Aeterna Zentaris, Vivus & Co.
Was für eine Woche! Obwohl sich der Gesamtmarkt schwach präsentiert hat, lassen sich mit SD-Tipps weiterhin regelmäßig riesige Kurs­gewinne in kürzester Zeit einfahren. Wir ...
21.01.14 - PR Newswire
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil)
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil) PR Newswire
07.11.13 - PR Newswire
Critical Alerts For YELP, VVUS, Sears, Sina Corp, and Xilinx Released By InvestorsObserver
Critical Alerts For YELP, VVUS, Sears, Sina Corp, and Xilinx Released By InvestorsObserver PR Newswire
06.11.13 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results - 3Q13 Total Net Revenues Increased by 52% vs. 3Q12 to $108.1 MM - PR Newswire
11.10.13 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA™ In The United States And Canada
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA™ In The United States And Canada - STENDRA Broadens Auxilium's Presence ...
12.06.13 - PR Newswire
Critical Alerts For Texas Instruments, Moody's, ONEOK, Illumina and Vivus Released By InvestorsObserver
Critical Alerts For Texas Instruments, Moody's, ONEOK, Illumina and Vivus Released By InvestorsObserver PR Newswire
18.04.13 - PR Newswire
Critical Alerts For Freeport-McMoran Copper & Gold, AFLAC, Michael Kors, Vivus, and Santarus Released By InvestorsObserver
Critical Alerts For Freeport-​McMoran Copper & Gold, AFLAC, Michael Kors, Vivus, and Santarus Released By InvestorsObserver PR Newswire
10.04.13 - PR Newswire
New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting
New Obesity Education Program To Premiere At American College of Physicians (ACP) Annual Meeting "EXCESS WEIGHT AND YOUR HEALTH" PROGRAM ENCOURAGES ...
07.03.13 - PR Newswire
VIVUS Launches Mobile App to Help Patients Lose Weight
VIVUS Launches Mobile App to Help Patients Lose Weight "Q AND ME" ENCOURAGES LIFESTYLE SKILLS TO AID IN LASTING WEIGHT LOSS PR Newswire
05.03.13 - PR Newswire
VIVUS Announces New Qsymia Offer
VIVUS Announces New Qsymia Offer GET STARTED! AND SAVE NOW! PROGRAMS PROVIDE APPROPRIATE NEW PATIENTS UP TO $150 SAVINGS* PR Newswire

Newssuche

Videos

newspaper
09:10 Uhr -2,20%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »